'de novo' AMP biosynthetic process

pathway activity — cross-omics
GO:0044208Cross-omicsRNA → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the 'de novo' AMP biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the BREAST cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PFAS, PPAT, and PAICS, each associated with the pathway in up to 20 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, 'de novo' AMP biosynthetic process activity versus PFAS in BREAST (Pearson r = 0.66).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BREASTPFAS →+1.365+0.135<.001<.001320
UPPER_AERODIGESTIVE_TRACTPPAT →+1.220+0.193<.001.001320
UPPER_AERODIGESTIVE_TRACTPAICS →+1.410+0.165<.001.003319
BLOOD_LymphomaTSR1 →+1.067+0.137<.001<.001318
BREASTGEMIN4 →+1.200+0.148<.001<.001318
OESOPHAGUSDHX33 →+1.147+0.184.004.006318
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0044208 vs PFAS — BREAST

Per-sample scatter of 'de novo' AMP biosynthetic process activity vs PFAS in BREAST.

Explore this scatter interactively →

Exploration